Company intelligence
Massachusetts Biomedical Initiatives (MBI)
Advancing Startups from Concept to Clinical Trials
About Massachusetts Biomedical Initiatives (MBI)
MBI supports early stage startups from Concept to Clinical Trials by offering flexible, private labs as a service. Our team offsets your early headcount and helps nurture your company through to clinical trials so you can get the data you need to secure investment and bring products to patients. MBI is also a leader in workforce and economic development for Central Massachusetts.
Verified activity
Signals from Massachusetts Biomedical Initiatives (MBI)
5 published signals
Partnerships
Massachusetts Biomedical Initiatives (MBI) company Eascra Biotech secured a nearly $8 million NASA contract to advance its work using microgravity to develop new approaches to drug delivery.
Reported by Massachusetts Biomedical Initiatives (MBI)
People
Massachusetts Biomedical Initiatives (MBI) promoted Marsha Rolle to Vice President of Strategic Programs.
Reported by Massachusetts Biomedical Initiatives (MBI)
Capital & Finance
Massachusetts Biomedical Initiatives (MBI) announced that Eascra Biotech expanded its lab space from one of its 366-square-foot StartUp labs to 1,272 square feet and a team of seven.
Reported by Massachusetts Biomedical Initiatives (MBI)
Capital & Finance
Massachusetts Biomedical Initiatives (MBI) announced that Eascra Biotech closed an $8 million financing round to support its next stage of growth.
Reported by Massachusetts Biomedical Initiatives (MBI)
Presence & Recognition
Massachusetts Biomedical Initiatives (MBI) participated in a Lunch & Learn panel discussion on Pitch Decks at Thursday's Lunch & Learn event.
Reported by Massachusetts Biomedical Initiatives (MBI)